CVR Medical (OTCMKTS:CRRVF) versus Tandem Diabetes Care (NASDAQ:TNDM) Critical Analysis

CVR Medical (OTCMKTS:CRRVF) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Analyst Ratings

This is a summary of current ratings for CVR Medical and Tandem Diabetes Care, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
Tandem Diabetes Care	0	3	15	0	2.83

Tandem Diabetes Care has a consensus price target of $53.81, indicating a potential upside of 64.77%. Given Tandem Diabetes Care’s stronger consensus rating and higher possible upside, analysts plainly believe Tandem Diabetes Care is more favorable than CVR Medical.

Profitability

This table compares CVR Medical and Tandem Diabetes Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
Tandem Diabetes Care	-14.84%	-44.19%	-11.99%

Risk and Volatility

CVR Medical has a beta of 22.67, suggesting that its share price is 2,167% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

Valuation and Earnings

This table compares CVR Medical and Tandem Diabetes Care”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	N/A	N/A	N/A
Tandem Diabetes Care	$854.35 million	2.51	-$222.61 million	($1.93)	-16.92

CVR Medical has higher earnings, but lower revenue than Tandem Diabetes Care.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About Tandem Diabetes Care

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.